The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackrock I&g Regulatory News (BRIG)

Share Price Information for Blackrock I&g (BRIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 188.50
Bid: 188.00
Ask: 189.00
Change: 2.00 (1.07%)
Spread: 1.00 (0.532%)
Open: 186.50
High: 188.50
Low: 184.00
Prev. Close: 186.50
BRIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

23 Apr 2021 13:00

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

BlackRock Income and Growth Investment Trust Plc - Portfolio Update

PR Newswire

London, April 23

The information contained in this release was correct as at 31 March 2021. Information on the Company’s up to date net asset values can be found on the London Stock Exchange Website at:

https://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html.

BLACKROCK INCOME & GROWTH INVESTMENT TRUST PLC (LEI:5493003YBY59H9EJLJ16)

All information is at 31 March 2021 and unaudited.

Performance at month end with net income reinvested

One MonthThree MonthsOne YearThree YearsFive YearsSince 1 April 2012
Sterling
Share price1.8%2.3%21.7%1.2%15.0%78.8%
Net asset value3.9%3.0%25.2%9.0%26.5%82.0%
FTSE All-Share Total Return4.0%5.2%26.7%9.9%35.7%76.5%
Source: BlackRock

BlackRock took over the investment management of the Company with effect from 1 April 2012.

At month end

Sterling:

Net asset value – capital only:189.45p
Net asset value – cum income*:191.51p
Share price:171.00p
Total assets (including income):£46.2m
Discount to cum-income NAV:10.7%
Gearing:8.3%
Net yield**:4.2%
Ordinary shares in issue***:22,017,990
Gearing range (as a % of net assets):0-20%
Ongoing charges****:1.2%
* Includes net revenue of 2.06 pence per share
** The Company’s yield based on dividends announced in the last 12 months as at the date of the release of this announcement is 4.2% and includes the 2020 final dividend of 4.60p per share declared on 01 February 2021 and paid to shareholders on 12 March 2021 and the 2020 interim dividend of 2.60p per share declared on 24 June 2020 and paid to shareholders on 1 September 2020.
*** excludes 10,081,532 shares held in treasury
**** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 31 October 2020.

Sector AnalysisTotal assets (%)
Financial Services10.7
Support Services9.9
Household Goods & Home Construction8.5
Pharmaceuticals & Biotechnology7.3
Mining7.1
Oil & Gas Producers6.3
Personal Goods5.8
General Retailers5.0
Banks5.0
Life Insurance4.9
Travel & Leisure4.1
Media4.0
Tobacco4.0
Nonlife Insurance3.0
Health Care Equipment & Services2.8
General Industrials2.3
Food & Drug Retailers2.0
Industrial Metals & Mining1.6
Electronic & Electrical Equipment1.4
Electricity1.1
Technology Hardware & Equipment0.9
Real Estate Investment Trusts0.6
Industrial Engineering0.6
Net Current Assets1.1
-----
Total100.0
=====

Country AnalysisPercentage
United Kingdom93.2
United States3.2
France1.4
Italy1.1
Net Current Assets1.1
-----
100.0
=====

Top 10 holdingsFund %
AstraZeneca6.0
Rio Tinto5.0
Reckitt Benckiser4.8
Unilever4.1
RELX4.0
British American Tobacco4.0
Royal Dutch Shell ‘B’3.8
Standard Chartered2.9
Smith & Nephew2.8
Phoenix Group2.8

Commenting on the markets, representing the Investment Manager noted:

Performance Overview:

The Company returned 3.9% during the month, underperforming the FTSE All-Share which returned 4.0%. 

Market Summary:

Global equity markets rose in March on the approval of further fiscal support and the restart to come. The UK and US continued the rollout of successful vaccine programmes while many European countries tightened lockdown restrictions again due to struggles with rising infection rates and a sluggish vaccination campaign.

Fiscal stimulus continued in the US with the approval of a COVID relief bill of $1.9 trillion. US Treasury yields climbed close to one-year highs with the 10-year yield near 1.5% early in the month. The FOMC meeting indicated the Fed’s higher tolerance for inflation and that tapering bond purchases remains a distant prospect.

On Budget Day in the UK, the Chancellor revealed several initiatives; one key positive included the 130% ‘super deduction’ tax incentive to promote near-term investment, and one key negative included a proposed increase in corporation tax to 25% pre-announced for April 2023, lifting the overall UK tax burden to its highest in 50 years. Progression of the roadmap out of lockdown continued late in the month with the permittance of 6 people or two households meeting outside. The FTSE All Share rose 4.0% during the month with Telecommunications, Consumer Goods and Utilities outperforming while Basic Materials and Oil & Gas underperformed.

Stocks:

Hiscox was a top detractor during the period; the company issued a poor trading statement that highlighted further investments needed within its retail business. Following recent floats and strong performance from Moonpig and The Hut Group earlier in the quarter, the share prices fell back during March; both companies were top detractors during the month.

Taylor Wimpey was a top positive contributor; the company had significant upgrades at the FY results owing to higher expected margins. Reckitt Benckiser benefitted as market optimism increased around the improved sales execution and Standard Chartered benefitted from the value rotation and rising interest rates; both companies were top positive contributors.

Portfolio Activity:

We remain constructive on economic growth and the tailwind to cyclical areas of the stock market while remaining cognisant of more defensive companies’ increasingly attractive free cash flow generation.

During the month we added to Ferguson where the strength in the macro and their ability to take share gave us confidence to further increase the position. We reduced Hiscox after the release of a disappointing trade statement where our investment thesis has been challenged in the short term. We sold our position in Rightmove as we see better opportunities in other parts of the Company.

Outlook:

Despite the continuation of COVID-19 lockdowns globally, economic activity has been less impacted as consumers and corporates have adapted their behaviours since the development of effective vaccines. Looking ahead, the focus is firmly on the cyclical recovery buoyed by ongoing monetary and fiscal support overwhelming concerns around virus variants.

As economic activity rebounds this has caused some strains on supply chains with specific industry shortages as well as building inflationary pressures including significant increases in commodity prices versus 12 months ago. The prospect of higher inflation has driven bond yields higher with central bankers indicating their willingness, for now, to stay on the side-lines. We are also cognisant of the evolution of relationships between China and the West and the potential impact on industries and shares.

Turning to the UK specifically, we have, finally, got a Brexit deal that provides increased clarity on the UK’s trading relationship with the EU. This is against a backdrop of UK valuations that have been extreme, trading at multi-decade lows versus other international markets with a recent flurry of M&A deals highlighting the dispersion and value on offer in the FTSE. We continue to believe that this dispersion should narrow given the increased certainty and reduced risk regarding Brexit in addition to the UK’s strong vaccination effort. 

We view the dividend outlook for the UK market with renewed optimism as we expect dividends, in aggregate, to be more resilient and to grow faster in the future as those companies that had been overdistributing for a number of years reset their dividends during the pandemic. Resilience was a crucial feature of the Company and its underlying holdings in 2020 and while this will still be important in 2021, we are excited by the approaching economic recovery and the opportunity to deliver strong capital and dividend growth for our clients over the long-term.

23 April 2021

Date   Source Headline
3rd May 202412:13 pmPRNNet Asset Value(s)
2nd May 202412:10 pmPRNNet Asset Value(s)
2nd May 20247:00 amPRNTotal Voting Rights
1st May 202412:10 pmPRNNet Asset Value(s)
1st May 20247:00 amPRNTotal Voting Rights
30th Apr 20244:04 pmPRNTransaction in Own Shares
30th Apr 202412:07 pmPRNNet Asset Value(s)
29th Apr 20245:02 pmPRNTransaction in Own Shares
29th Apr 202412:25 pmPRNNet Asset Value(s)
29th Apr 20247:00 amPRNTotal Voting Rights
26th Apr 202411:45 amPRNNet Asset Value(s)
26th Apr 20247:00 amPRNTotal Voting Rights
25th Apr 20245:30 pmPRNTransaction in Own Shares
25th Apr 202412:14 pmPRNNet Asset Value(s)
24th Apr 20243:59 pmPRNTransaction in Own Shares
24th Apr 202412:15 pmPRNNet Asset Value(s)
23rd Apr 20244:44 pmPRNPortfolio Update
23rd Apr 202412:13 pmPRNNet Asset Value(s)
22nd Apr 202411:54 amPRNNet Asset Value(s)
19th Apr 202412:06 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 202412:16 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20246:03 pmPRNTransaction in Own Shares
17th Apr 202412:13 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:49 pmPRNTransaction in Own Shares
16th Apr 202412:02 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:10 pmPRNTransaction in Own Shares
15th Apr 202411:37 amPRNNet Asset Value(s)
15th Apr 20247:00 amPRNTotal Voting Rights
12th Apr 20244:32 pmPRNTransaction in Own Shares
12th Apr 202412:14 pmPRNNet Asset Value(s)
12th Apr 20247:00 amPRNTotal Voting Rights
11th Apr 20243:57 pmPRNTransaction in Own Shares
11th Apr 202412:11 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 20245:18 pmPRNTransaction in Own Shares
10th Apr 202412:06 pmPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20243:35 pmPRNTransaction in Own Shares
9th Apr 202411:45 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20245:15 pmPRNTransaction in Own Shares
8th Apr 202411:59 amPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights
5th Apr 20245:44 pmPRNTransaction in Own Shares
5th Apr 202412:15 pmPRNNet Asset Value(s)
5th Apr 20247:00 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.